
On
May 23, 2025, Hospitalar 2025, the highly anticipated international
medical device exhibition in the global healthcare industry,
successfully concluded at the São Paulo Expo in Brazil.
The event attracted over 1,200 exhibitors from more than 60
countries, showcasing the latest advancements in global medical
technology and the insights of industry leaders. It provided
unprecedented opportunities for cross - border collaboration among
various stakeholders.

Dr.
Waleska Santos, Founder and President of Hospitalar, stated in her
opening - ceremony speech, "For over 30 years, Hospitalar has served as
the industry's hub. By integrating policies with the industry, we have
been promoting the widespread availability of medical technology."

During
the exhibition, numerous professional conferences and forums were held.
Hundreds of experts, scholars, and thousands of participants discussed
global medical research achievements, development trends, as well as the
challenges and opportunities in areas such as innovation, universal
access, and cross - border cooperation. Discussions ranged from smart
healthcare and telemedicine to medical big data and AI - assisted
diagnosis, with the exchange of ideas charting the course for industry
development.

At
Hospitalar 2025, WINMEDIC prominently displayed its innovative digital
pathology products. The Win - Pro series digital slide scanners, in
particular, received high acclaim from on - site experts and industry
professionals. Their high - precision imaging, efficient scanning speed,
and the powerful image - processing capabilities of the WinQuant
multifunctional pathological image analysis software were highly
regarded. Many attendees stopped at the booth to experience the
scanners' fast and accurate scanning performance and intelligent
analysis functions firsthand, noting that the technology offered an
innovative solution for enhancing the efficiency of pathological
diagnosis.

Looking
ahead, WINMEDIC will continue to deepen innovation and research in the
field of digital pathology, simultaneously advancing its global market
strategy. With a deep focus on the application requirements of digital
pathology, the company aims to provide more innovative and practical end
- to - end pathological solutions for customers worldwide.
